Based on SEC filing data. A biotech corporation based in Seattle, WA raised $450,000 through a convertible note in Series B funding. The company is at the growth stage and operating in the biotechnology sector.
Get notified the moment Nativis, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.